TAKE THE LEAD: INSIDE OMNI EDGE

Maximize the power of early intervention.

Engineered for precision. Designed for comprehensive intervention. Backed by proven clinical performance.2,3,4,6,7
Drive Change Now
how omni wins
Your Performance Dashboard
Engineered for consistent wins.
Intervene sooner. Preserve longer. With exceptional feel and precision. OMNI Edge drives your ability to treat all stages of primary open-angle glaucoma.
Proven Performance
Multiple studies have demonstrated the safety, effectiveness, and durability of the OMNI procedure.

Supported by long-term data from GEMINI,6 ROMEO,3 and the IRIS® Registry.4
OMNI Procedures
Over 300,000 OMNI procedures performed.5

The OMNI family of products has established itself as the leader in canal-based MIGS.
Technology

Consistency without compromise.

OMNI Edge with TruSyncTM Technology is a patented viscoelastic delivery technology synchronized with surgeon rotation of the control wheel - enabling consistent, predictable, and reproducible viscoelastic deployment along every treated clock hour of Schlemm's canal.
The Glaucoma Journey
Driving the glaucoma circuit
Stay on track.
The race is on against glaucoma—and OMNI is built to lead. Whether combined with cataract surgery or for pseudophakic patients, OMNI delivers a comprehensive solution at every stage, empowering surgeons to stay ahead.
Intervene Early
Preserve the Vision that Matters

Help your patients find their way at every turn in the road.

Act early to protect vision longer. Pseudophakic patients can benefit from early interventional glaucoma.
See how OMNI changes the course
How it works
Inside OMNI Edge
Unlock the OMNI Ultimate Experience
Discover precision, versatility, and confidence in every detail OMNI brings to MIGS procedures.
Request a Demo

Our Community

United on a Mission to Preserve Sight

Our drive to innovate combined with proven clinical excellence has made us a trusted partner to the eyecare community.

Hear More from the Drivers

I have used OMNI since 2018, and I have to say with 100% confidence that it is my favorite MIGS device

Monisha Vora, MD

Monisha Vora
Monisha Vora, MD

1. The OMNI® Edge Surgical System is indicated for canaloplasty followed by trabeculotomy to reduce intraocular pressure (IOP) in adult patients with primary open-angle glaucoma. Please visit omnisurgical.com/instructionsforuse for the full instructions for use, warnings, precautions, and adverse event information.
2. Hirsch L, et al. Canaloplasty and trabeculotomy ab interno with the OMNI system combined with cataract surgery in open-angle glaucoma: 12-month outcomes from the ROMEO study. J Cataract Refract Surg 2021; 47:907–915.
3. Williamson B, et al. Canaloplasty and Trabeculotomy with OMNI System in Patients with Open-Angle Glaucoma: Two-Year Results from the ROMEO study. Clinical Ophthalmology 2023: 17 1-10.
4. Radcliffe, Nathan M, et al. Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System in Eyes with Primary Open-Angle Glaucoma: A 36-Month Analysis from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) American Journal of Ophthalmology, Volume 271, 436 – 444.
5. Estimate based on units of OMNI (and predicates) shipped as of Dec 31, 2024.
6. Greenwood M, et al. 36-Month Outcomes from the Prospective GEMINI Study: Canaloplasty and Trabeculotomy Combined with Cataract Surgery for Patients with Primary Open-Angle Glaucoma. Clinical Ophthalmology 2023:17 3817-3824.
7. Yadgarov A, et al. Real-World Outcomes of Canaloplasty and Trabeculotomy Combined with Cataract Surgery in Eyes with All Stages of Open-Angle Glaucoma. Clinical Ophthalmology 2023:17 2609-2617.

OM-3641-US.v2

Join in the race against glaucoma.

Get Started